Skip to main content

Table 1 Baseline characteristics of the 290 patients

From: Clinical impact of bacterial contamination of perfusion fluid in kidney transplantation

 

Contaminated PF (n = 101)

Non-contaminated PF (n = 189)

Donor

 Age, years

61.3 ± 13.9

59.7 ± 15.3

 Cold ischemia time, h

16.4 ± 3.8

15.8 ± 4.2

Recipient

 Age, years

55.7 ± 11.6

54.8 ± 11.5

 Sex (M/F)

69/32

129/60

Induction ID, No. (%)

 Thymoglobulin

7 (7)

3 (1)

 Basiliximab

100 (99)

186 (98)

 Rituximab

2 (2)

0

Maintenance ID, No. (%)

 Tacrolimus

88 (87.1)

142 (75.1)

 Cyclosporine

9 (8)

35 (18)

 Mycophenolate mofetil

77 (76.2)

133 (70.3)

 Everolimus

5 (5)

17 (9)

 Azathoprine

0

3 (1)

 Steroids

98 (97)

182 (96.3)

  1. Continuous variables are expressed as mean ± SD
  2. PF perfusion fluid, ID immunosuppression therapy